Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 12953
TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 81356BDBM81356(PF-3845, 10 | US20240308985, Comparator TableD2.2 ...)
Affinity DataIC50: 14nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50307083BDBM50307083(4-nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carb...)
Affinity DataIC50: 459nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696920BDBM696920(US20240308985, Comparator 521 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696911BDBM696911(US20240308985, Comparator 406 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696810BDBM696810(US20240308985, Compound 373 | US20250170100, Compa...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696909BDBM696909(US20240308985, Comparator 404 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696908BDBM696908(US20240308985, Comparator 403 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696907BDBM696907(US20240308985, Comparator 402 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696906BDBM696906(US20240308985, Comparator 400 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696905BDBM696905(US20240308985, Comparator 395 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696904BDBM696904(US20240308985, Comparator 391 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696919BDBM696919(US20240308985, Comparator 495 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696818BDBM696818(US20240308985, Compound 408 | US20250170100, Compa...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696917BDBM696917(US20240308985, Comparator 445 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696916BDBM696916(US20240308985, Comparator 442 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696915BDBM696915(US20240308985, Comparator 441 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 744076BDBM744076(US20250170100, Comparator 427)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696913BDBM696913(US20240308985, Comparator 424 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696912BDBM696912(US20240308985, Comparator 416 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696895BDBM696895(US20240308985, Comparator 181 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696894BDBM696894(US20240308985, Comparator 179 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 744055BDBM744055(US20250170100, Comparator 155)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 744054BDBM744054(US20250170100, Comparator 154)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 744053BDBM744053(US20250170100, Comparator 153)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696892BDBM696892(US20240308985, Comparator 152 | US20240308985, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696891BDBM696891(US20240308985, Comparator 150 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696845BDBM696845(US20240308985, Compound 142 | US20250170100, Compa...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696903BDBM696903(US20240308985, Comparator 388 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696902BDBM696902(US20240308985, Comparator 384 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696901BDBM696901(US20240308985, Comparator 368 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696900BDBM696900(US20240308985, Comparator 198 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696899BDBM696899(US20240308985, Comparator 188 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696898BDBM696898(US20240308985, Comparator 184 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696897BDBM696897(US20240308985, Comparator 183 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696896BDBM696896(US20240308985, Comparator 182 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 744041BDBM744041(US20250170100, Compound 120)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 697152BDBM697152(US20240308985, Compound 117 | US20250170100, Compo...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696889BDBM696889(US20240308985, Comparator 144 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696888BDBM696888(US20240308985, Comparator 123 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696840BDBM696840(US20240308985, Compound 493 | US20250170100, Compo...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696829BDBM696829(US20240308985, Compound 473 | US20250170100, Compo...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696677BDBM696677(US20240308985, Compound 127 | US20250170100, Compo...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696640BDBM696640(US20240308985, Compound 125 | US20250170100, Compo...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696888BDBM696888(US20240308985, Comparator 123 | US20250170100, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 696639BDBM696639(US20240308985, Compound 122 | US20250170100, Compo...)
Affinity DataIC50: 1.00E+4nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
9/22/2025
Entry Details
US Patent